The therapeutic function of BEZ235, which inhibits PI3K (p110-α, -β, -γ, and -δ isoforms) and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes, has been widely demonstrated in various cancers (41, –, 43). The gene discussed is PIK3CD; the disease is cancer.